Toll Free: 1-888-928-9744
Published: Oct, 2018 | Pages:
115 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
In 2017, the global Meningococcal Conjugate Vaccine market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Meningococcal Conjugate Vaccine market based on company, product type, application and key regions. This report studies the global market size of Meningococcal Conjugate Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Meningococcal Conjugate Vaccine in these regions. This research report categorizes the global Meningococcal Conjugate Vaccine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis. The various contributors involved in the value chain of Meningococcal Conjugate Vaccine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Meningococcal Conjugate Vaccine include GlaxoSmithKline Pfizer Sanofi Market Size Split by Type Menactra MENVEO Market Size Split by Application Children Adults Market size split by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Meningococcal Conjugate Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. To understand the structure of Meningococcal Conjugate Vaccine market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Meningococcal Conjugate Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Meningococcal Conjugate Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market. To project the value and volume of Meningococcal Conjugate Vaccine submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Meningococcal Conjugate Vaccine are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Meningococcal Conjugate Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Study Coverage 1.1 Meningococcal Conjugate Vaccine Product 1.2 Key Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Meningococcal Conjugate Vaccine Market Size Growth Rate by Type 1.4.2 Menactra 1.4.3 MENVEO 1.5 Market by Application 1.5.1 Global Meningococcal Conjugate Vaccine Market Size Growth Rate by Application 1.5.2 Children 1.5.3 Adults 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Meningococcal Conjugate Vaccine Market Size 2.1.1 Global Meningococcal Conjugate Vaccine Revenue 2016-2025 2.1.2 Global Meningococcal Conjugate Vaccine Sales 2016-2025 2.2 Meningococcal Conjugate Vaccine Growth Rate by Regions 2.2.1 Global Meningococcal Conjugate Vaccine Sales by Regions 2.2.2 Global Meningococcal Conjugate Vaccine Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Meningococcal Conjugate Vaccine Sales by Manufacturers 3.1.1 Meningococcal Conjugate Vaccine Sales by Manufacturers 3.1.2 Meningococcal Conjugate Vaccine Sales Market Share by Manufacturers 3.1.3 Global Meningococcal Conjugate Vaccine Market Concentration Ratio (CR5 and HHI) 3.2 Meningococcal Conjugate Vaccine Revenue by Manufacturers 3.2.1 Meningococcal Conjugate Vaccine Revenue by Manufacturers (2016-2018) 3.2.2 Meningococcal Conjugate Vaccine Revenue Share by Manufacturers (2016-2018) 3.3 Meningococcal Conjugate Vaccine Price by Manufacturers 3.4 Meningococcal Conjugate Vaccine Manufacturing Base Distribution, Product Types 3.4.1 Meningococcal Conjugate Vaccine Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Meningococcal Conjugate Vaccine Product Category 3.4.3 Date of International Manufacturers Enter into Meningococcal Conjugate Vaccine Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type 4.1 Global Meningococcal Conjugate Vaccine Sales by Type 4.2 Global Meningococcal Conjugate Vaccine Revenue by Type 4.3 Meningococcal Conjugate Vaccine Price by Type 5 Breakdown Data by Application 5.1 Overview 5.2 Global Meningococcal Conjugate Vaccine Breakdown Data by Application 6 North America 6.1 North America Meningococcal Conjugate Vaccine by Countries 6.1.1 North America Meningococcal Conjugate Vaccine Sales by Countries 6.1.2 North America Meningococcal Conjugate Vaccine Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Meningococcal Conjugate Vaccine by Type 6.3 North America Meningococcal Conjugate Vaccine by Application 6.4 North America Meningococcal Conjugate Vaccine by Company 7 Europe 7.1 Europe Meningococcal Conjugate Vaccine by Countries 7.1.1 Europe Meningococcal Conjugate Vaccine Sales by Countries 7.1.2 Europe Meningococcal Conjugate Vaccine Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Meningococcal Conjugate Vaccine by Type 7.3 Europe Meningococcal Conjugate Vaccine by Application 7.4 Europe Meningococcal Conjugate Vaccine by Company 8 Asia Pacific 8.1 Asia Pacific Meningococcal Conjugate Vaccine by Countries 8.1.1 Asia Pacific Meningococcal Conjugate Vaccine Sales by Countries 8.1.2 Asia Pacific Meningococcal Conjugate Vaccine Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Meningococcal Conjugate Vaccine by Type 8.3 Asia Pacific Meningococcal Conjugate Vaccine by Application 8.4 Asia Pacific Meningococcal Conjugate Vaccine by Company 9 Central & South America 9.1 Central & South America Meningococcal Conjugate Vaccine by Countries 9.1.1 Central & South America Meningococcal Conjugate Vaccine Sales by Countries 9.1.2 Central & South America Meningococcal Conjugate Vaccine Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Meningococcal Conjugate Vaccine by Type 9.3 Central & South America Meningococcal Conjugate Vaccine by Application 9.4 Central & South America Meningococcal Conjugate Vaccine by Company 10 Middle East and Africa 10.1 Middle East and Africa Meningococcal Conjugate Vaccine by Countries 10.1.1 Middle East and Africa Meningococcal Conjugate Vaccine Sales by Countries 10.1.2 Middle East and Africa Meningococcal Conjugate Vaccine Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Meningococcal Conjugate Vaccine by Type 10.3 Middle East and Africa Meningococcal Conjugate Vaccine by Application 10.4 Middle East and Africa Meningococcal Conjugate Vaccine by Company 11 Company Profiles 11.1 GlaxoSmithKline 11.1.1 GlaxoSmithKline Company Details 11.1.2 Company Description 11.1.3 Sales, Revenue and Gross Margin of Meningococcal Conjugate Vaccine 11.1.4 Meningococcal Conjugate Vaccine Product Description 11.1.5 Recent Development 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Company Description 11.2.3 Sales, Revenue and Gross Margin of Meningococcal Conjugate Vaccine 11.2.4 Meningococcal Conjugate Vaccine Product Description 11.2.5 Recent Development 11.3 Sanofi 11.3.1 Sanofi Company Details 11.3.2 Company Description 11.3.3 Sales, Revenue and Gross Margin of Meningococcal Conjugate Vaccine 11.3.4 Meningococcal Conjugate Vaccine Product Description 11.3.5 Recent Development 12 Market Opportunities, Challenges, Risks and Influences Factors Analysis 12.1 Market Opportunities and Drivers 12.2 Market Challenges 12.3 Market Risks/Restraints 12.4 Key World Economic Indicators 13 Value Chain and Sales Channels Analysis 13.1 Value Chain Analysis 13.1.1 Typical Suppliers of Key Meningococcal Conjugate Vaccine Raw Material 13.1.2 Meningococcal Conjugate Vaccine Customers 13.2 Sales Channels Analysis 13.2.1 Sales Channels Analysis 13.2.2 Distributors 14 Research Findings and Conclusion 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Author Details 15.3 Disclaimer
List of Tables and Figures Figure Picture of Meningococcal Conjugate Vaccine Figure Global Meningococcal Conjugate Vaccine Production (K Doses) and CAGR (%) Comparison by Types (Product Category) (2013-2025) Figure Global Meningococcal Conjugate Vaccine Production Market Share by Types (Product Category) in 2017 Figure Menactra Product Picture Table Major Manufacturers of Menactra Figure MENVEO Product Picture Table Major Manufacturers of MENVEO Table Global Meningococcal Conjugate Vaccine Market Size Growth Rate by Application 2018-2025 (K Doses) Figure Children Figure Adults Figure Meningococcal Conjugate Vaccine Report Years Considered Figure Global Meningococcal Conjugate Vaccine Market Size 2016-2025 (Million US$) Figure Global Meningococcal Conjugate Vaccine Sales 2016-2025 (K Doses) Table Global Meningococcal Conjugate Vaccine Market Size by Regions 2016-2025 (K Doses) & (Million US$) Table Global Meningococcal Conjugate Vaccine Sales by Regions 2016-2025 (K Doses) Table Global Meningococcal Conjugate Vaccine Sales Market Share by Regions 2016-2025 Figure Global Meningococcal Conjugate Vaccine Sales Market Share by Regions 2016-2025 Figure 2017 Global Meningococcal Conjugate Vaccine Sales Market Share by Regions Table Global Meningococcal Conjugate Vaccine Revenue by Regions 2016-2025 (Million US$) Table Global Meningococcal Conjugate Vaccine Revenue Market Share by Regions 2016-2025 Figure Global Meningococcal Conjugate Vaccine Revenue Market Share by Regions 2016-2025 Figure 2017 Global Meningococcal Conjugate Vaccine Revenue Market Share by Regions Table Global Meningococcal Conjugate Vaccine Sales by Manufacturers (2016-2018) (K Doses) Table Global Meningococcal Conjugate Vaccine Sales Share by Manufacturers (2016-2018) Figure Global Meningococcal Conjugate Vaccine Sales Share by Manufacturers in 2017 Table Meningococcal Conjugate Vaccine Revenue by Manufacturers (2016-2018) (Million US$) Table Meningococcal Conjugate Vaccine Revenue Share by Manufacturers (2016-2018) Figure Meningococcal Conjugate Vaccine Value Share by Manufacturers in 2017 Table Global Meningococcal Conjugate Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Manufacturers Meningococcal Conjugate Vaccine Price (2016-2018) (USD/Dose) Table Meningococcal Conjugate Vaccine Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Meningococcal Conjugate Vaccine Product Category Table Date of International Manufacturers Enter into Meningococcal Conjugate Vaccine Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Meningococcal Conjugate Vaccine Sales by Type (2016-2025) (K Doses) Table Global Meningococcal Conjugate Vaccine Sales Share by Type (2016-2025) Figure Global Meningococcal Conjugate Vaccine Sales Market Share by Type (2016-2025) Figure Global Meningococcal Conjugate Vaccine Sales Market Share by Type in 2017 Table Global Meningococcal Conjugate Vaccine Revenue by Type (2016-2025) (Million US$) Table Global Meningococcal Conjugate Vaccine Revenue Share by Type (2016-2025) Figure Global Meningococcal Conjugate Vaccine Revenue Market Share by Type (2016-2025) Figure Global Meningococcal Conjugate Vaccine Revenue Market Share by Type in 2017 Table Meningococcal Conjugate Vaccine Price by Type 2013-2018 (USD/Dose) Table Global Meningococcal Conjugate Vaccine Sales by Application (2016-2025) (K Doses) Table Global Meningococcal Conjugate Vaccine Sales Share by Application (2016-2025) Figure Global Sales Meningococcal Conjugate Vaccine Market Share by Application (2016-2025) Figure Global Sales Meningococcal Conjugate Vaccine Market Share by Application (2016-2025) Figure North America Meningococcal Conjugate Vaccine Sales Growth Rate 2016-2025 (K Doses) Figure North America Meningococcal Conjugate Vaccine Revenue Growth Rate 2016-2025 (Million US$) Table North America Meningococcal Conjugate Vaccine Sales by Countries (2016-2025) (K Doses) Table North America Meningococcal Conjugate Vaccine Sales Market Share by Countries (2016-2025) Figure 2017 North America Meningococcal Conjugate Vaccine Sales Market Share by Countries Table North America Meningococcal Conjugate Vaccine Revenue by Countries (2016-2025) (Million US$) Table North America Meningococcal Conjugate Vaccine Revenue Market Share by Countries (2016-2025) Figure 2017 North America Meningococcal Conjugate Vaccine Revenue Market Share by Countries Figure United States Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure United States Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Figure Canada Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure Canada Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Figure Mexico Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure Mexico Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Table North America Meningococcal Conjugate Vaccine Sales by Type (2016-2025) (K Doses) Table North America Meningococcal Conjugate Vaccine Sales Market Share by Type (2016-2025) Figure 2017 North America Meningococcal Conjugate Vaccine Market Share by Type Table North America Meningococcal Conjugate Vaccine Sales by Application (2016-2025) (K Doses) Table North America Meningococcal Conjugate Vaccine Sales Market Share by Application (2016-2025) Figure 2017 North America Meningococcal Conjugate Vaccine Market Share by Application Table North America Meningococcal Conjugate Vaccine Sales by Company (2016-2018) (K Doses) Table North America Meningococcal Conjugate Vaccine Sales Market Share by Company (2016-2018) Figure North America Meningococcal Conjugate Vaccine Sales Market Share by Company in 2017 Figure Europe Meningococcal Conjugate Vaccine Sales Growth Rate 2016-2025 (K Doses) Figure Europe Meningococcal Conjugate Vaccine Revenue Growth Rate 2016-2025 (Million US$) Table Europe Meningococcal Conjugate Vaccine Sales by Countries (2016-2025) (K Doses) Table Europe Meningococcal Conjugate Vaccine Sales Market Share by Countries (2016-2025) Figure 2017 Europe Meningococcal Conjugate Vaccine Sales Market Share by Countries Table Europe Meningococcal Conjugate Vaccine Revenue by Countries (2016-2025) (Million US$) Table Europe Meningococcal Conjugate Vaccine Revenue Market Share by Countries (2016-2025) Figure 2017 Europe Meningococcal Conjugate Vaccine Revenue Market Share by Countries Figure Germany Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure Germany Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (K Doses) Figure France Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure France Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (K Doses) Figure UK Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure UK Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Figure Italy Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure Italy Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Figure Russia Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure Russia Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Table Europe Meningococcal Conjugate Vaccine Sales by Type (2016-2025) (K Doses) Table Europe Meningococcal Conjugate Vaccine Sales Market Share by Type (2016-2025) Figure 2017 Europe Meningococcal Conjugate Vaccine Market Share by Type Table Europe Meningococcal Conjugate Vaccine Sales by Application (2016-2025) (K Doses) Table Europe Meningococcal Conjugate Vaccine Sales Market Share by Application (2016-2025) Figure 2017 Europe Meningococcal Conjugate Vaccine Market Share by Application Table Europe Meningococcal Conjugate Vaccine Sales by Company (2016-2018) (K Doses) Table Europe Meningococcal Conjugate Vaccine Sales Market Share by Company (2016-2018) Figure Europe Meningococcal Conjugate Vaccine Sales Market Share by Company in 2017 Figure Asia Pacific Meningococcal Conjugate Vaccine Sales Growth Rate 2016-2025 (K Doses) Figure Asia Pacific Meningococcal Conjugate Vaccine Revenue Growth Rate 2016-2025 (Million US$) Table Asia Pacific Meningococcal Conjugate Vaccine Sales by Countries (2016-2025) (K Doses) Table Asia Pacific Meningococcal Conjugate Vaccine Sales Market Share by Countries (2016-2025) Figure 2017 Asia Pacific Meningococcal Conjugate Vaccine Sales Market Share by Countries Table Asia Pacific Meningococcal Conjugate Vaccine Revenue by Countries (2016-2025) (Million US$) Table Asia Pacific Meningococcal Conjugate Vaccine Revenue Market Share by Countries (2016-2025) Figure 2017 Asia Pacific Meningococcal Conjugate Vaccine Revenue Market Share by Countries Figure China Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure China Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Figure Japan Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure Japan Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Figure Korea Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure Korea Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Figure India Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure India Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Figure Australia Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure Australia Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Figure Indonesia Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure Indonesia Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Figure Malaysia Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure Malaysia Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Figure Philippines Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure Philippines Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Figure Thailand Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure Thailand Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Figure Vietnam Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure Vietnam Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Figure Singapore Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure Singapore Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Table Asia Pacific Meningococcal Conjugate Vaccine Sales by Type (2016-2025) (K Doses) Table Asia Pacific Meningococcal Conjugate Vaccine Sales Market Share by Type (2016-2025) Figure 2017 Asia Pacific Meningococcal Conjugate Vaccine Market Share by Type Table Asia Pacific Meningococcal Conjugate Vaccine Sales by Application (2016-2025) (K Doses) Table Asia Pacific Meningococcal Conjugate Vaccine Sales Market Share by Application (2016-2025) Figure 2017 Asia Pacific Meningococcal Conjugate Vaccine Market Share by Application Table Asia Pacific Meningococcal Conjugate Vaccine Sales by Company (2016-2018) (K Doses) Table Asia Pacific Meningococcal Conjugate Vaccine Sales Market Share by Company (2016-2018) Figure Asia Pacific Meningococcal Conjugate Vaccine Sales Market Share by Company in 2017 Figure Central & South America Meningococcal Conjugate Vaccine Sales Growth Rate 2016-2025 (K Doses) Figure Central & South America Meningococcal Conjugate Vaccine Revenue Growth Rate 2016-2025 (Million US$) Table Central & South America Meningococcal Conjugate Vaccine Sales by Countries (2016-2025) (K Doses) Table Central & South America Meningococcal Conjugate Vaccine Sales Market Share by Countries (2016-2025) Figure 2017 Central & South America Meningococcal Conjugate Vaccine Sales Market Share by Countries Table Central & South America Meningococcal Conjugate Vaccine Revenue by Countries (2016-2025) (Million US$) Table Central & South America Meningococcal Conjugate Vaccine Revenue Market Share by Countries (2016-2025) Figure 2017 Central & South America Meningococcal Conjugate Vaccine Revenue Market Share by Countries Figure Brazil Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure Brazil Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Figure Argentina Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure Argentina Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Table Central & South America Meningococcal Conjugate Vaccine Sales by Type (2016-2025) (K Doses) Table Central & South America Meningococcal Conjugate Vaccine Sales Market Share by Type (2016-2025) Figure 2017 Central & South America Meningococcal Conjugate Vaccine Market Share by Type Table Central & South America Meningococcal Conjugate Vaccine Sales by Application (2016-2025) (K Doses) Table Central & South America Meningococcal Conjugate Vaccine Sales Market Share by Application (2016-2025) Figure 2017 Central & South America Meningococcal Conjugate Vaccine Market Share by Application Table Central & South America Meningococcal Conjugate Vaccine Sales by Company (2016-2018) (K Doses) Table Central & South America Meningococcal Conjugate Vaccine Sales Market Share by Company (2016-2018) Figure Central & South America Meningococcal Conjugate Vaccine Sales Market Share by Company in 2017 Figure Middle East and Africa Meningococcal Conjugate Vaccine Sales Growth Rate 2016-2025 (K Doses) Figure Middle East and Africa Meningococcal Conjugate Vaccine Revenue Growth Rate 2016-2025 (Million US$) Table Middle East and Africa Meningococcal Conjugate Vaccine Sales by Countries (2016-2025) (K Doses) Table Middle East and Africa Meningococcal Conjugate Vaccine Sales Market Share by Countries (2016-2025) Figure 2017 Middle East and Africa Meningococcal Conjugate Vaccine Sales Market Share by Countries Table Middle East and Africa Meningococcal Conjugate Vaccine Revenue by Countries (2016-2025) (Million US$) Table Middle East and Africa Meningococcal Conjugate Vaccine Revenue Market Share by Countries (2016-2025) Figure 2017 Middle East and Africa Meningococcal Conjugate Vaccine Revenue Market Share by Countries Figure GCC Countries Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure GCC Countries Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Figure Turkey Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure Turkey Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Figure Egypt Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure Egypt Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Figure South Africa Meningococcal Conjugate Vaccine Sales Growth Rate (2016-2025) (K Doses) Figure South Africa Meningococcal Conjugate Vaccine Revenue Growth Rate (2016-2025) (Million US$) Table Middle East and Africa Meningococcal Conjugate Vaccine Sales by Type (2016-2025) (K Doses) Table Middle East and Africa Meningococcal Conjugate Vaccine Sales Market Share by Type (2016-2025) Figure 2017 Middle East and Africa Meningococcal Conjugate Vaccine Market Share by Type Table Middle East and Africa Meningococcal Conjugate Vaccine Sales by Application (2016-2025) (K Doses) Table Middle East and Africa Meningococcal Conjugate Vaccine Sales Market Share by Application (2016-2025) Figure 2017 Middle East and Africa Meningococcal Conjugate Vaccine Market Share by Application Table Middle East and Africa Meningococcal Conjugate Vaccine Sales by Company (2016-2018) (K Doses) Table Middle East and Africa Meningococcal Conjugate Vaccine Sales Market Share by Company (2016-2018) Figure Middle East and Africa Meningococcal Conjugate Vaccine Sales Market Share by Company in 2017 Table GlaxoSmithKline Company Details Table GlaxoSmithKline Meningococcal Conjugate Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018) Table GlaxoSmithKline Recent Development Table Pfizer Company Details Table Pfizer Meningococcal Conjugate Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018) Table Pfizer Recent Development Table Sanofi Company Details Table Sanofi Meningococcal Conjugate Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018) Table Sanofi Recent Development Figure GDP by Regions / Largest Economies Pie Chart in 2016 Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060 Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016 Figure Saving Rate Total, % of GDP, 2015 Table Meningococcal Conjugate Vaccine Value Chain Table Typical Suppliers of Key Meningococcal Conjugate Vaccine Raw Material Table Meningococcal Conjugate Vaccine Customers List Table Meningococcal Conjugate Vaccine Sales Channels Table Meningococcal Conjugate Vaccine Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.